Intelligent Ultrasound Group PLC Notice of Results (1282J)

TIDMIUG

RNS Number : 1282J

Intelligent Ultrasound Group PLC

25 April 2022

Intelligent Ultrasound Group plc

(the "Company")

Notice of results

Analyst briefing

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound artificial intelligence (AI) software and simulation company, announces it will issue its unaudited preliminary results for the year ended 31 December 2021 on Tuesday, 3 May 2022.

The Company will host a briefing for analysts via ZOOM at 9.30am on Tuesday, 3 May. If you would like to register to dial in to the analyst briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email [e-mail].

For further information, please contact:

 
Intelligent Ultrasound Group                                www. intelligentultrasound.com 
 plc 
Stuart Gall, CEO                                                  Tel: [phone] 
 
Helen Jones, CFO 
 
 
Cenkos Securities - Nominated Advisor                             Tel: [phone] 
 and Broker 
Giles Balleny (Corporate 
 Finance) 
Michael Johnson / Julian 
 Morse (Sales) 
 
 
 
Walbrook PR               Tel: [phone] or [e-mail] 
Anna Dunphy / Paul McManus                             Mob: [phone] / Mob: +44 
                                                                           (0)7980 541 893 
 
 
 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

Simulation

Focusses on real-time hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,350 simulators have been sold to over 650 medical institutions around the world.

Clinical AI software

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound guided needling and incorporates ScanNav Anatomy PNB.

www.intelligentultrasound.com

NOTE: ScanNav Anatomy PNB is not yet available for sale in the US or any other territory requiring government approval for this type of product.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORGZGZDDDKGZZM

(END) Dow Jones Newswires

April 25, 2022 02:01 ET (06:01 GMT)